PTAB Delivers Mixed Rulings on Medtronic Bladder and Bowel Control Patents

In recent developments, the Patent Trial and Appeal Board (PTAB) offered mixed rulings on two patents held by medical device heavyweight, Medtronic. These results come after the patents were contested by a competitor in the sector.

In the divide of decisions, PTAB sustained one patented invention by Medtronic pertaining to an electrical stimulation apparatus implemented for the treatment of bladder and bowel control loss. On the flip side, the board decided in favor of the challenger on the second patent, effectively trimming Medtronic’s claim.

Interactions like this serve to underline the competitive nature of the medical device field, with firms continually investing in research and development while simultaneously warding off challenges from rivals. As more detailed information of the case unfolds, it must be intriguing to observe the potential impact of the rulings on both – Medtronic and the competitor. Dive into the case details here.